Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks and ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...
At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...
More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy. Walmart will offer in-store pickup for Zepbound at ...
While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 medications like Ozempic and Wegovy may be changing something broader: the consumer ...
GLP-1s have proven to be highly effective for obesity, but are extremely expensive and often have serious side effects, such as nausea, vomiting, dizziness and fatigue. That’s why Noom, a digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback